Kubota Pharmaceutical Holdings Co., Ltd.

Against a background of the globally strengthening R&D focus on rare diseases, Japan is seeing unusually fierce competition in the relatively small indication of Stargardt disease, a rare ophthalmolog

While Novartis AG ’s Zolgensma (onasemnogene abeparvovec) was not the first gene therapy to be commercialized in Japan, its pricing and launch in May marked a watershed moment as it became the single

The ophthalmology-focused biotech, France’s Horama SAS , has just completed recruitment of several individuals to its executive team and is now raising additional investment funding via a series B

IN VITRO DIAGNOSTICS ALLIANCES Akers Biosciences Inc. Alere Inc. First Check Diagnostics LLC Akers Biosciences Inc. licensed Alere Inc. 's First Check Diagnostics LLC exclusive US distribut